Evidence map›Paper›PMID 38178667›Full record

ReviewCurrent drug delivery2025

Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.

Bhupendra Dixena, Rashmi Madhariya, Anupama Panday, Alpana Ram, Akhlesh K Jain

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bhupendra DixenaDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, (C.G.) 495009, India.ORCID 0000-0002-4696-9613
Rashmi MadhariyaDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, (C.G.) 495009, India.ORCID 0000-0002-4801-5813
Anupama PandayDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, (C.G.) 495009, India.ORCID 0000-0003-1425-7109
Alpana RamDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, (C.G.) 495009, India.ORCID 0000-0002-6182-3452
Akhlesh K JainDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, (C.G.) 495009, India.ORCID 0000-0002-6420-9773
Guru Ghasidas Vishwavidyalaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransdermal drug delivery systems (TDDS) offer several advantages over traditional methods such as injections and oral administration. These advantages include preventing first-pass metabolism, providing consistent and sustained activity, reducing side effects, enabling the use of short half-life drugs, improving physiological response, and enhancing patient convenience. However, the permeability of skin poses a challenge for TDDS, as it is impermeable to large molecules and hydrophilic drugs but permeable to small molecules and lipophilic drug. To overcome this barrier, researchers have investigated vesicular systems, such as transfersomes, liposomes, niosomes, and ethosomes. Among these vesicular systems, transfersomes are particularly promising for noninvasive drug administration due to their deformability and flexible membrane. They have been extensively studied for delivering anticancer drugs, insulin, corticosteroids, herbal medicines, and NSAIDs through the skin. Transfersomes have demonstrated efficacy in treating skin cancer, improving insulin delivery, enhancing site-specific corticosteroid delivery, and increasing the permeation and therapeutic effects of herbal medicines. They have also been effective in delivering pain relief with minimal side effects using NSAIDs and opioids. Transfersomes have been used for transdermal immunization and targeted drug delivery, offering site-specific release and minimizing adverse effects. Overall, transfersomes are a promising approach for transdermal drug delivery in various therapeutic applications.

objectiveThe aim of the present review is to discuss the various advantages and limitations of transfersomes and their mechanism to penetration across the skin, as well as their application for the delivery of various drugs like anticancer, antidiabetic, NSAIDs, herbal drugs, and transdermal immunization.

methodsData we searched from PubMed, Google Scholar, and ScienceDirect.

resultsIn this review, we have explored the various methods of preparation of transfersomes and their application for the delivery of various drugs like anticancer, antidiabetic, NSAIDs, herbal drugs, and transdermal immunization.

conclusionIn comparison to other vesicular systems, transfersomes are more flexible, have greater skin penetration capability, can transport systemic medicines, and are more stable. Transfersomes are capable of delivering both hydrophilic and hydrophobic drugs, making them suitable for transdermal drug delivery. The developed transfersomal gel could be used to improve medicine delivery through the skin.

Indexed as

Drug Delivery SystemsSkinAdministration, CutaneousAnimalsHumansLiposomesPharmaceutical PreparationsSkin AbsorptionLiposomesPharmaceutical Preparationsdrug deliveryedge activatorherbal drugs.insulinligand conjugated transfersomestransdermal immunizationTransfersomes

Identifiers

PMID38178667
OpenAlexW4390612058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.